Literature DB >> 21207039

Clinical analysis of the risk factors of slow coronary flow.

Shuang Xia1, Song-Bai Deng, Yang Wang, Jun Xiao, Jian-Lin Du, Yu Zhang, Xi-Chun Wang, Ye-Qing Li, Rui Zhao, Li He, Yu-Luan Xiang, Qiang She.   

Abstract

Slow coronary flow (SCF) phenomenon is a coronary microvascular disorder characterized by the delayed passage of contrast in the absence of obstructive epicardial coronary disease, and is an important clinical entity because it may be the cause of precordial pain when the body is at rest and/or during exercise. Although clinical and pathological features of SCF have been previously described, its etiopathogenesis remains unclear. The present study aims to investigate the risk factors of slow coronary flow, in order to provide the foundation for further exploration of potential mechanisms of SCF. A total of 47 consecutive patients with documented slow coronary flow, and 33 patients with normal coronary flow--as defined by TIMI frame count (TFC)--were recruited for this study. Clinical information was collected, and biochemical indicators including high-sensitivity C-reactive protein (hs-CRP), and a marker of systemic inflammation were detected. Logistic regression analysis was performed for statistical analysis. SCF patients had a higher level of serum uric acid (323.2 ± 79.3 vs. 282.8 ± 82.4 μmol/l, p = 0.03), 2-h postprandial blood glucose (8.6 ± 2.7 vs. 7.5 ± 1.8 mmol/l, p = 0.04), platelet count (165.9 ± 51.6 × 10(3) vs. 127.0 ± 32.0 × 10(3) cells/μl, p = 0.0003) and hs-CRP (3.4 ± 0.8 vs. 2.0 ± 0.9 mg/l, p < 0.0001) than those of patients in the control group. No marked differences in other variables were observed between the two groups. Logistic regression showed serum uric acid level (χ(2) = 3.84, β = 0.007, p = 0.049), 2-h postprandial blood glucose (χ(2) = 5.02, β = 0.277, p = 0.025) and blood platelet count (χ(2) = 12.16, β = 0.026, p = 0.001) were independent predictors of SCF. When hs-CRP was included in the multivariate model, hs-CRP (χ(2) = 21.19, β = 1.90, p < 0.0001) was the only independent predictor of SCF. These findings suggested that an elevation of serum uric acid level, 2-h postprandial blood glucose, and blood platelet count might be the causes of SCF, and inflammation was likely to be implicated in the causal pathway leading to SCF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207039     DOI: 10.1007/s00380-010-0081-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  44 in total

1.  Aborted sudden cardiac death in a 20-year-old man with slow coronary flow.

Authors:  Basri Amasyali; Hasan Turhan; Sedat Kose; Turgay Celik; Atila Iyisoy; Hurkan Kursaklioglu; Ersoy Isik
Journal:  Int J Cardiol       Date:  2005-07-27       Impact factor: 4.164

2.  Increased mean platelet volume in patients with slow coronary flow.

Authors:  Nihat Sen; Nurcan Basar; Orhan Maden; Firat Ozcan; Mehmet Fatih Ozlu; Omer Gungor; Kumral Cagli; Ali Riza Erbay; Yucel Balbay
Journal:  Platelets       Date:  2009-02       Impact factor: 3.862

3.  The relation between impaired glucose tolerance and slow coronary flow.

Authors:  Emrah Binak; Huseyin Gunduz; Muslum Sahin; Nuri Kurtoglu; Ismet Dindar
Journal:  Int J Cardiol       Date:  2005-11-16       Impact factor: 4.164

4.  In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets.

Authors:  S Asano; A Okano; K Ozawa; T Nakahata; T Ishibashi; K Koike; H Kimura; Y Tanioka; A Shibuya; T Hirano
Journal:  Blood       Date:  1990-04-15       Impact factor: 22.113

5.  Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials).

Authors:  Hung Q Ly; Ajay J Kirtane; Sabina A Murphy; Jacki Buros; Christopher P Cannon; Eugene Braunwald; C Michael Gibson
Journal:  Am J Cardiol       Date:  2006-04-27       Impact factor: 2.778

6.  Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

Authors:  Marilda Mazzali; John Kanellis; Lin Han; Lili Feng; Yi-Yang Xia; Qiang Chen; Duk-Hee Kang; Katherine L Gordon; Susumu Watanabe; Takahiko Nakagawa; Hui Y Lan; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2002-06

7.  Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.

Authors:  H Kawano; T Motoyama; O Hirashima; N Hirai; Y Miyao; T Sakamoto; K Kugiyama; H Ogawa; H Yasue
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

8.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

9.  Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.

Authors:  Leo K Niskanen; David E Laaksonen; Kristiina Nyyssönen; Georg Alfthan; Hanna-Maaria Lakka; Timo A Lakka; Jukka T Salonen
Journal:  Arch Intern Med       Date:  2004-07-26

10.  Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro.

Authors:  T Imai; K Koike; T Kubo; T Kikuchi; Y Amano; M Takagi; N Okumura; T Nakahata
Journal:  Blood       Date:  1991-10-15       Impact factor: 22.113

View more
  13 in total

1.  Effect of myocardial contractility on hemodynamic end points under concomitant microvascular disease in a porcine model.

Authors:  Srikara Viswanath Peelukhana; Kranthi K Kolli; Massoud A Leesar; Mohamed A Effat; Tarek A Helmy; Imran Arif; Eric W Schneeberger; Paul Succop; Rupak K Banerjee
Journal:  Heart Vessels       Date:  2013-04-30       Impact factor: 2.037

2.  Serum uric acid as a surrogate marker of favorable response to bevacizumab treatment in patients with metastatic colon cancer.

Authors:  F Selcukbiricik; M Kanbay; Y Solak; A Bilici; M Kanıtez; E Balık; N M Mandel
Journal:  Clin Transl Oncol       Date:  2016-01-19       Impact factor: 3.405

3.  The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study.

Authors:  Halit Zengin; Ali Rıza Erbay; Ali Okuyucu; Hasan Alaçam; Serkan Yüksel; Murat Meriç; Korhan Soylu; Ömer Gedikli; Naci Murat; Okan Gülel; Sabri Demircan; Filiz Akın; Özcan Yılmaz; Mahmut Şahin
Journal:  Anatol J Cardiol       Date:  2014-04-28       Impact factor: 1.596

4.  Relationship between platelet-to-lymphocyte ratio and coronary slow flow.

Authors:  Muhammed Oylumlu; Adnan Doğan; Mustafa Oylumlu; Abdülkadir Yıldız; Murat Yüksel; Fethullah Kayan; Celal Kilit; Basri Amasyalı
Journal:  Anatol J Cardiol       Date:  2014-04-08       Impact factor: 1.596

5.  Focusing on a complete blood cell parameter: mean platelet volume levels may be a predictor of coronary slow flow.

Authors:  Mücahid Yılmaz; Mustafa Necati Dağlı; Ökkeş Uku; Mehmet Nail Bilen; Hasan Korkmaz; Kenan Erdem; Ertuğrul Kurtoğlu
Journal:  Vasc Health Risk Manag       Date:  2017-07-07

6.  Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants.

Authors:  Fatemeh Rahimi-Sakak; Mahsa Maroofi; Jamal Rahmani; Nick Bellissimo; Azita Hekmatdoost
Journal:  BMC Cardiovasc Disord       Date:  2019-10-15       Impact factor: 2.298

7.  Echocardiographic and laboratory findings in coronary slow flow phenomenon: cross-sectional study and review.

Authors:  Mir Hosein Seyyed Mohammadzad; Kamal Khademvatani; Salar Gardeshkhah; Amin Sedokani
Journal:  BMC Cardiovasc Disord       Date:  2021-05-05       Impact factor: 2.298

8.  Effect of Coronary Slow Flow on Intrinsicoid Deflection of QRS Complex.

Authors:  Sabri Seyis
Journal:  Cardiol Res Pract       Date:  2018-02-01       Impact factor: 1.866

9.  Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study.

Authors:  Saibal Mukhopadhyay; Mitesh Kumar; Jamal Yusuf; Vinod Kumar Gupta; Sanjay Tyagi
Journal:  Indian Heart J       Date:  2017-09-04

10.  Relationship of serum salusin beta levels with coronary slow flow.

Authors:  Aydın Akyüz; Fatma Aydın; Şeref Alpsoy; Demet Ozkaramanli Gur; Savas Guzel
Journal:  Anatol J Cardiol       Date:  2019-09       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.